Cited by 530interferon and immune responsesCytokine Signaling Pathways and InteractionsNF-κB Signaling Pathways

Complex modulation of cell type-specific signaling in response to type I interferons

Open access
van Boxel-Dezaire, Anette H.H., Rani, M.R. Sandhya, Stark, George R.·2006·Immunity

Abstract

The type I interferons (IFNs) are pleiotropic cytokines that regulate many different cellular functions. The major signaling pathway activated by type I IFNs involves sequential phosphorylation of the tyrosine residues of the Janus kinase (JAK) and signal transducers and activators of transcription (STAT) proteins, providing the primary mechanism through which gene expression is induced. Recent work has shown that the responses are quite complex, as shown by different responses to specific subtypes of type I IFN, activation of kinases in addition to JAKs, patterns of activation of all seven STATs in different cells, and activation of transcription factors other than STATs. The type I IFNs use this complexity to regulate many different biological functions in different types of cells, by activating different specific signals and patterns of gene expression.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2006.08.014

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R.
Affiliations
Cleveland Clinic (US)
Corresponding author
Stark, George R.
Venue
Immunity
Publisher
Elsevier BV
Published
2006-09
Volume
25
Issue
3
Pages
361-372
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2040653543
Cited by
530
References
125
Citations by year
2026: 10 · 2025: 14 · 2024: 16 · 2023: 15 · 2022: 23 · 2021: 33 · 2020: 21 · 2019: 26 · 2018: 16 · 2017: 26 · 2016: 30 · 2015: 33 · 2014: 28 · 2013: 29 · 2012: 30
FWCI
16.07
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (P01CA062220)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
type I interferon, JAK/STAT signaling, cell type-specific signaling, STAT phosphorylation, interferon subtypes, kinase activation, transcription factors, gene expression regulation, cytokine signaling
MeSH terms
Animals, Blood Cells, Humans, Interferon Type I, Signal Transduction, STAT Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review